Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alimera Sciences Company Profile (NASDAQ:ALIM)

Consensus Ratings for Alimera Sciences (NASDAQ:ALIM) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (93.59% upside)

Analysts' Ratings History for Alimera Sciences (NASDAQ:ALIM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/7/2015Cantor FitzgeraldInitiated CoverageBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
11/17/2014Summer StreetInitiated CoverageBuy -> Buy$12.00ViewTweet This Rating  Share This Rating on StockTwits
9/29/2014Northland SecuritiesBoost Price TargetOutperform$7.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Northland SecuritiesBoost Price Target$7.00ViewTweet This Rating  Share This Rating on StockTwits
10/28/2013Cowen and CompanyUpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/8/2013Northland Capital PartnersInitiated CoverageOutperform$5.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013Northland SecuritiesInitiated CoverageOutperform$5.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 1/28/2013 forward)